Dragana Savic | INIA Biosciences Co-Founder & Co-CEO

A visionary entrepreneur and innovator, Dragana Savic leads INIA Biosciences in revolutionizing the treatment of systemic inflammation through a non-invasive, ultrasound-based wearable device that targets the splenic nerve to activate the cholinergic anti-inflammatory pathway. By offering a safer, more effective alternative to biologics and immunosuppressants, her technology stands at the forefront of biotech and medical device innovation, addressing widespread inflammatory conditions like psoriasis. Driven by a passion for biomedical advancement, Dragana seeks non-entrepreneurial support to collaborate with research institutions, clinicians, and regulatory bodies to accelerate clinical adoption, enhance global health outcomes, and establish INIA’s groundbreaking platform as a new standard of care.